Novanta beats Q3 revenue, adjusted profit estimates

Novanta

03/11/2025 22:09

Overview

Novanta Q3 revenue increased 1.4% to $247.8 mln, beating analyst expectations

Adjusted EPS for Q3 was $0.87, exceeding analyst estimates

Adjusted EBITDA for Q3 missed analyst expectations

Outlook

Novanta expects Q4 2025 GAAP revenue of $253 mln to $257 mln

Company forecasts full-year 2025 GAAP revenue of $975 mln to $979 mln

Novanta anticipates mid-single digit organic revenue growth in 2026

Result Drivers

ACQUISITIONS AND CURRENCY - Revenue increase driven by acquisitions and favorable currency exchange rates, offset by negative organic growth

ADVANCED SURGERY GROWTH - Significant growth in Advanced Surgery business contributed to positive results

BOOKINGS INCREASE - 17% year-over-year increase in bookings indicates strong demand

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$247.80 mln
$245.95 mln (3 Analysts)
Q3 Adjusted EPS
Beat
$0.87
$0.81 (3 Analysts)
Q3 Consolidated Net Income
$10.7 mln
Q3 Adjusted EBITDA
Miss
$58.1 mln
$58.22 mln (2 Analysts)
Q3 Adjusted Operating Income
Beat
$47.4 mln
$43.67 mln (2 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the electronic equipment & parts peer group is "buy"

Wall Street's median 12-month price target for Novanta Inc is $150.00, about 15.3% above its October 31 closing price of $127.01

The stock recently traded at 35 times the next 12-month earnings vs. a P/E of 33 three months ago

Press Release: ID:nBw3rNsrja

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)